GeneLink, Inc. GNLKQ

GNLKQ Company Overview

GeneLink, Inc. (OTC: GNLKQ) was a U.S.-based biotechnology and consumer genetics company focused on personalized health, nutrigenomics, and DNA-based wellness products. The company operated in the broader healthcare, biotechnology, and direct-to-consumer genetic testing industries, with business activities centered on genetic analysis designed to support personalized nutrition, skincare, and wellness recommendations.

Public disclosures and historical market filings indicate that the company’s primary revenue drivers were genetic testing services, consumer wellness programs, and commercialization of DNA-based lifestyle products through affiliated marketing and distribution channels. GeneLink became known for attempting to combine molecular diagnostics with consumer health applications during the early growth phase of personalized medicine and nutrigenomics. Available public information suggests the company underwent significant financial distress and restructuring activity, and trading under the “Q” suffix historically indicated bankruptcy-related status in OTC markets. Data regarding current operations and active commercial status is inconclusive based on available public sources.